A photoactivated Ir(iii) complex targets cancer stem cells and induces secretion of damage-associated molecular patterns in melanoma cells characteristic of immunogenic cell death

The new iridium complex selectively targets cancer stem cells and has potential to induce immunogenic cell death in cancer cells.

• Publication year

  2021

• Venue

  Inorganic Chemistry Frontiers

• Publication date

  2021-09-06

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1039/d1qi00856k
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A photocaged, water-oxidizing, and nucleolus-targeted Pt(IV) complex with a distinct anticancer mechanism.

  2020cited by this paper
• Unravelling the Mechanism of Excited-State Interligand Energy Transfer and the Engineering of Dual Emission in [Ir(C∧N)2(N∧N)]+ Complexes.

  2020cited by this paper
• New Opportunities in Cancer Immunotherapy and Theranostics.

  2020cited by this paper
• Sulfur-coordinated organoiridium(III) complexes exert anti-breast cancer activity via inhibiting Wnt/β-catenin signaling.

  2020cited by this paper
• Induction of immunogenic cell death in cancer cells by a photoactivated platinum(IV) prodrug.

  2020cited by this paper
• Regulatory approval of photoimmunotherapy: photodynamic therapy that induces immunogenic cell death

  2020cited by this paper
• Emerging Metallopharmaceuticals for the Treatment of Cancer

  2020cited by this paper
• Endoplasmic Reticulum Targeting to Amplify Immunogenic Cell Death for Cancer Immunotherapy.

  2020cited by this paper
• Near-infrared absorbing Ru(ii) complexes act as immunoprotective photodynamic therapy (PDT) agents against aggressive melanoma

  2020cited by this paper
• Immunogenic Cell Death of Breast Cancer Stem Cells Induced by an Endoplasmic Reticulum‐Targeting Copper(II) Complex

  2020cited by this paper
• Ru(ii) photosensitizers competent for hypoxic cancers via green light activation.

  2020cited by this paper
• Anticancer Cyclometalated Iridium(III) Complexes with Planar Ligands: Mitochondrial DNA Damage and Metabolism Disturbance.

  2019cited by this paper
• Tuning the Optical Properties of Novel Antitumoral Drugs Based on Cyclometalated Ir(III) Complexes.

  2019cited by this paper
• Molecular superoxide radical photogeneration in cancer cells by dipyridophenazine iridium(iii) complexes

  2019cited by this paper
• A mitochondria-targeted iridium(iii)-based photoacid generator induces dual-mode photodynamic damage within cancer cells.

  2019cited by this paper
• Photodynamic therapy of melanoma by blue-light photoactivation of flavin mononucleotide

  2019cited by this paper
• First-in-class ruthenium anticancer drug (KP1339/IT-139) induces an immunogenic cell death signature in colorectal spheroids in vitro.

  2019cited by this paper
• Towards Novel Photodynamic Anticancer Agents Generating Superoxide Anion Radicals: A Cyclometalated IrIII Complex Conjugated to a Far-Red Emitting Coumarin.

  2019cited by this paper
• Oxaliplatin-Based Platinum(IV) Prodrug Bearing Toll-like Receptor 7 Agonist for Enhanced Immunochemotherapy

  2019cited by this paper
• Smart Nanovesicle Mediated Immunogenic Cell Death through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy.

  2019cited by this paper
• Platinum Derivatives Effects on Anticancer Immune Response

  2019cited by this paper
• Mitochondria-Targeting Immunogenic Cell Death Inducer Improves the Adoptive T-Cell Therapy Against Solid Tumor

  2019cited by this paper
• An aminophosphonate ester ligand-containing platinum(ii) complex induces potent immunogenic cell death in vitro and elicits effective anti-tumour immune responses in vivo.

  2019cited by this paper
• Targeted photoredox catalysis in cancer cells

  2019cited by this paper
• Exploring the Effect of Polypyridyl Ligands on the Anticancer Activity of Phosphorescent Iridium(III) Complexes: From Proteosynthesis Inhibitors to Photodynamic Therapy Agents.

  2018cited by this paper
• Metal Drugs and the Anticancer Immune Response.

  2018cited by this paper
• Recent Advances in the Design of Targeted Iridium(III) Photosensitizers for Photodynamic Therapy

  2018cited by this paper
• Development and Validation of Liquid Chromatography-Based Methods to Assess the Lipophilicity of Cytotoxic Platinum(IV) Complexes

  2018cited by this paper
• Cyclometalated iridium(III) luminescent complexes in therapy and phototherapy

  2018cited by this paper
• Toward understanding cancer stem cell heterogeneity in the tumor microenvironment

  2018cited by this paper
• Cyclometalated iridium(iii) N-heterocyclic carbene complexes as potential mitochondrial anticancer and photodynamic agents.

  2017cited by this paper
• Tuning the Ground State and Excited State Properties of Monocationic Iridium(III) Complexes by Varying the Site of Benzannulation on Diimine Ligand.

  2017cited by this paper
• Dual Functions of Cyclometalated Iridium(III) Complexes: Anti-Metastasis and Lysosome-Damaged Photodynamic Therapy.

  2017cited by this paper
• Electrocatalytic CO2 reduction using rhenium(I) complexes with modified 2-(2′-pyridyl)imidazole ligands

  2017cited by this paper
• Advances in Photocatalysis: A Microreview of Visible Light Mediated Ruthenium and Iridium Catalyzed Organic Transformations.

  2016cited by this paper
• Breast Cancer Stem Cell Potent Copper(II)-Non-Steroidal Anti-Inflammatory Drug Complexes.

  2016cited by this paper
• Iridium(III) 2‐Phenylbenzimidazole Complexes: Synthesis, Structure, Optical Properties, and Applications in Dye‐Sensitized Solar Cells

  2016cited by this paper
• Immunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translation

  2016cited by this paper
• Highly potent extranuclear-targeted luminescent iridium(iii) antitumor agents containing benzimidazole-based ligands with a handle for functionalization.

  2016cited by this paper
• Cyclometalated Ir(iii) complexes containing quinoline-benzimidazole-based N^N ancillary ligands: structural and luminescence modulation by varying the substituent groups or the protonation/deprotonation state of imidazole units.

  2016cited by this paper
• Metal Complexes for Two‐Photon Photodynamic Therapy: A Cyclometallated Iridium Complex Induces Two‐Photon Photosensitization of Cancer Cells under Near‐IR Light

  2016cited by this paper
• Anticancer metal drugs and immunogenic cell death.

  2016cited by this paper
• Phosphorescent iridium(III)-bis-N-heterocyclic carbene complexes as mitochondria-targeted theranostic and photodynamic anticancer agents.

  2015cited by this paper
• Induction of immunogenic cell death by chemotherapeutic platinum complexes.

  2015cited by this paper
• Cyclometalated iridium( III ) complexes as lysosome-targeted photodynamic anticancer and real-time tracking agents

  2015cited by this paper
• Redox Regulation in Cancer Stem Cells

  2015cited by this paper
• Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal

  2015cited by this paper
• Luminescent Rhenium(I) and Iridium(III) Polypyridine Complexes as Biological Probes, Imaging Reagents, and Photocytotoxic Agents.

  2015cited by this paper
• Bright Building Blocks for Chemical Biology

  2014cited by this paper
• The Potent Oxidant Anticancer Activity of Organoiridium Catalysts

  2014cited by this paper
• Advanced Cell Culture Techniques for Cancer Drug Discovery

  2014cited by this paper
• ER stress, autophagy and immunogenic cell death in photodynamic therapy-induced anti-cancer immune responses

  2014cited by this paper
• Immunogenic cell death in cancer therapy.

  2013cited by this paper
• Spheroid culture as a tool for creating 3D complex tissues.

  2013cited by this paper
• Crosstalk between ER stress and immunogenic cell death.

  2013cited by this paper
• Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs

  2012cited by this paper
• Immunogenic cell death and DAMPs in cancer therapy

  2012cited by this paper
• Cancer stem cells.

  2012cited by this paper
• Enlightening the impact of immunogenic cell death in photodynamic cancer therapy

  2012cited by this paper
• A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death

  2012cited by this paper
• DAMPs and PDT-mediated photo-oxidative stress: exploring the unknown

  2011cited by this paper
• Synthesis and characterization of novel bis(carboxylato)dichloridobis(ethylamine)platinum(IV) complexes with higher cytotoxicity than cisplatin

  2011cited by this paper
• The time domain in co-stained cell imaging: time-resolved emission imaging microscopy using a protonatable luminescent iridium complex.

  2010cited by this paper
• Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway

  2010cited by this paper
• Combating melanoma: the use of photodynamic therapy as a novel, adjuvant therapeutic tool.

  2010cited by this paper
• Immunogenic death of colon cancer cells treated with oxaliplatin

  2010cited by this paper
• CD20-immunotargeting of malignant melanoma.

  2010cited by this paper
• Mechanisms of pre‐apoptotic calreticulin exposure in immunogenic cell death

  2009cited by this paper
• Synthesis of phenanthrimidazole from 9,10-phenanthraquinone and aldehydes by molecular iodine as catalyst

  2009cited by this paper
• Identification of selective inhibitors of cancer stem cells by high-throughput screening.

  2009cited by this paper
• Neutral red uptake assay for the estimation of cell viability/cytotoxicity

  2008cited by this paper
• Phosphatidylserine (PS) induces PS receptor–mediated macropinocytosis and promotes clearance of apoptotic cells

  2001cited by this paper

• Design and clinical advances of smart photoresponsive systems in cancer theranostics

  2026cites this paper
• An efficient ICD inducer based on Ir(III) cyclometalated complex for anticancer and anti-migration effects towards cisplatin-resistant cancer cells

  2025cites this paper
• Metal Complexes Diversity: Synthesis, Conformation, and Bioactivity

  2025cites this paper
• Immunogenic cell death inducers:Current advances and future perspectives

  2025cites this paper
• Rhenium(I) coordinated carbon nitride as type II immunogenic cell death inducers for enhancing photoimmunotherapy against Triple-Negative breast cancer

  2024cites this paper
• Two-photon phototriggering of ROS storm in ruthenium(II) coordinated carbon nitride for robust cancer immunotherapy

  2024cites this paper
• The copper (II) complex of salicylate phenanthroline induces immunogenic cell death of colorectal cancer cells through inducing endoplasmic reticulum stress.

  2024cites this paper
• Cyclometalated iridium(III) complex based on isoquinoline alkaloid synergistically elicits the ICD response and IDO inhibition via autophagy-dependent ferroptosis

  2024cites this paper
• Mitochondria- and endoplasmic reticulum-localizing iridium(III) complexes induce immunogenic cell death of 143B cells.

  2024cites this paper
• Trans-[Pt(amine)Cl2(PPh3)] Complexes Target Mitochondria and Endoplasmic Reticulum in Gastric Cancer Cells

  2024cites this paper
• Exploring Structure–Activity Relationships in Photodynamic Therapy Anticancer Agents Based on Ir(III)-COUPY Conjugates

  2023cites this paper
• Recent developments on other platinum metal complexes as target-specific anticancer therapeutics

  2023cites this paper
• Platinum(IV) Derivatives of [Pt(1S,2S-diaminocyclohexane)(5,6-dimethyl-1,10-phenanthroline)] with Diclofenac Ligands in the Axial Positions: A New Class of Potent Multi-action Agents Exhibiting Selectivity to Cancer Cells

  2023cites this paper
• Potent Zinc(II)-Based Immunogenic Cell Death Inducer Triggered by ROS-Mediated ERS and Mitochondrial Ca2+ Overload.

  2023cites this paper
• Metal-based Nanoparticles in Cancer Therapy: Exploring Photodynamic Therapy and its Interplay with Regulated Cell Death Pathways.

  2023cites this paper
• Targeting chemotherapy-resistant tumour sub-populations using inorganic chemistry: Anti-cancer stem cell metal complexes.

  2022cites this paper
• Dipyridophenazine iridium(III) complex as a phototoxic cancer stem cell selective, mitochondria targeting agent.

  2022cites this paper
• Target Profiling of an Iridium(III)-Based Immunogenic Cell Death Inducer Unveils the Engagement of Unfolded Protein Response Regulator BiP.

  2022cites this paper